MARZIONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 7.671
EU - Europa 3.722
AS - Asia 1.825
SA - Sud America 464
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 13.806
Nazione #
US - Stati Uniti d'America 7.610
UA - Ucraina 661
SG - Singapore 550
IT - Italia 511
CN - Cina 484
RU - Federazione Russa 461
IE - Irlanda 449
BR - Brasile 435
DE - Germania 401
SE - Svezia 400
HK - Hong Kong 310
DK - Danimarca 228
TR - Turchia 182
FI - Finlandia 172
GB - Regno Unito 161
FR - Francia 133
KR - Corea 116
VN - Vietnam 57
CI - Costa d'Avorio 50
MA - Marocco 43
IN - India 40
NL - Olanda 40
CA - Canada 37
BE - Belgio 23
PL - Polonia 22
ES - Italia 19
AT - Austria 18
JP - Giappone 17
BD - Bangladesh 16
MX - Messico 15
IQ - Iraq 10
UZ - Uzbekistan 8
AR - Argentina 7
PK - Pakistan 7
ZA - Sudafrica 7
EC - Ecuador 6
EU - Europa 6
RO - Romania 6
EG - Egitto 5
LT - Lituania 5
CO - Colombia 4
IR - Iran 4
PY - Paraguay 4
RS - Serbia 4
TN - Tunisia 4
AZ - Azerbaigian 3
CL - Cile 3
HN - Honduras 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
PW - Palau 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.806
Città #
Chandler 785
Jacksonville 711
Ashburn 608
Fairfield 605
Dallas 585
Dublin 448
Des Moines 427
Boardman 392
Hong Kong 309
Singapore 289
Woodbridge 283
Wilmington 274
Houston 255
Seattle 224
New York 221
Cambridge 211
Centro 202
Lawrence 163
Princeton 163
San Mateo 151
The Dalles 128
Ann Arbor 125
Moscow 90
Hefei 86
San Diego 83
Munich 80
Beijing 78
Los Angeles 60
Washington 57
Abidjan 50
London 43
Guangzhou 36
Turku 35
São Paulo 33
Turin 31
Shanghai 30
Ancona 29
Helsinki 25
Nuremberg 24
Wuhan 23
Brooklyn 18
Brussels 17
Norwalk 17
Rio de Janeiro 17
Marche 16
Pune 16
Columbus 15
Ho Chi Minh City 15
Santa Clara 15
Warsaw 15
Wuxi 14
Chicago 13
Council Bluffs 13
Hanoi 13
Jiaxing 12
Montreal 12
Salamanca 12
Brasília 10
Torre Annunziata 10
Kilburn 9
Ottawa 9
Stockholm 9
Vienna 9
Atlanta 8
Fayetteville 8
Izmir 8
Perugia 8
San Francisco 8
Chennai 7
Falls Church 7
Frankfurt am Main 7
Rome 7
Tokyo 7
Antwerp 6
Appignano 6
Aversa 6
Belo Horizonte 6
Civitanova Marche 6
Johannesburg 6
Mexico City 6
Milan 6
New Bedfont 6
Redmond 6
Senigallia 6
Tashkent 6
Toronto 6
Andover 5
Ankara 5
Baghdad 5
Curitiba 5
Lahore 5
Manchester 5
Osasco 5
Porto Alegre 5
Quanzhou 5
Salvador 5
Aracaju 4
Belgrade 4
Boston 4
Bragança Paulista 4
Totale 8.977
Nome #
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 166
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 165
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 150
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 143
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 132
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 125
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 121
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 119
Aging and the Biological Response to Liver Injury 118
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 118
Descriptive epidemiology of cholangiocarcinoma in Italy. 117
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 114
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 114
Hepatitis E in a region of Italy: An emerging autochthonous infection? 114
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 112
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 111
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 111
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 111
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 110
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 110
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 107
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 106
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 105
Clinical implications of novel aspects of biliary pathophysiology. 105
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 105
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 104
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 104
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 104
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 103
Cholangiocarcinoma development: the resurgence of bile acids 103
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 103
Leptin enhances cholangiocarcinoma cell growth. 102
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 102
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 102
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 101
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 100
Functional and Structural Features of Cholangiocytes in Health and Disease 99
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 98
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 98
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 97
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 97
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 97
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 96
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 95
Current targets for Primary Sclerosing cholangitis 95
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 95
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 95
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 95
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 92
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 92
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 92
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 92
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 91
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 91
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 91
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 90
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 90
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 90
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 89
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 88
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 88
Functional heterogeneity of the intrahepatic biliary tree 87
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 87
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 87
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 87
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 87
Role of apoptosis in development of primary biliary cirrhosis 86
Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP 86
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 86
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 85
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 85
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 85
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 84
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 84
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 83
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 83
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 83
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 83
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 81
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 81
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 80
Role of cholangiocytes in primary biliary cirrhosis 79
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 79
Primary Biliary Cholangitis: advances in management and treatment of the disease 79
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 78
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 78
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 78
NUOVA METODICA DIAGNOSTICA PER LE NEOPLASIE DEL PANCREAS 76
Small Mouse cholangiocytes proliferate in response to H1 Histamine receptor stimulation by activation of the IP3/CAMK I/CREB pathway. 75
The significance of genetics for cholangiocarcinoma development 75
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 75
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 74
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 74
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 74
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 74
Cholangiocytes in health and disease: From basic science to novel treatments 74
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 73
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases 72
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 72
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances 72
Totale 9.591
Categoria #
all - tutte 85.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.995 0 0 303 63 283 142 186 189 208 244 229 148
2021/20221.384 72 356 19 37 15 68 80 85 68 100 223 261
2022/20232.548 215 204 144 196 158 623 4 165 616 13 161 49
2023/20241.542 254 34 118 306 245 328 16 29 11 28 10 163
2024/20252.825 328 280 106 45 86 115 161 96 714 206 286 402
2025/20261.403 508 456 439 0 0 0 0 0 0 0 0 0
Totale 14.221